ST1926 repression of Tax: ATL targeted treatment?
Authors:
Open Access
- 25 September 2014
- journal article
- editorial
- Published by American Society of Hematology in Blood
- Vol. 124 (13) , 2009-2011
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Preclinical efficacy of the synthetic retinoid ST1926 for treating adult T-cell leukemia/lymphomaBlood, 2014
- Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemiaJournal of Experimental Medicine, 2010
- Meta-Analysis on the Use of Zidovudine and Interferon-Alfa in Adult T-Cell Leukemia/Lymphoma Showing Improved Survival in the Leukemic SubtypesJournal of Clinical Oncology, 2010
- Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective studyBlood, 2010
- Identification of cancer stem cells in a Tax-transgenic (Tax-Tg) mouse model of adult T-cell leukemia/lymphomaBlood, 2009
- Clinical efficacy of all-trans retinoic acid for treating adult T cell leukemiaJournal of Cancer Research and Clinical Oncology, 2007
- Does theHBZGene Represent a New Potential Target for the Treatment of Adult T-Cell Leukemia?International Reviews of Immunology, 2007
- Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type INature Medicine, 2006
- N-(4-hydroxyphenyl)retinamide induces growth arrest and apoptosis in HTLV-I-transformed cellsLeukemia, 2003
- A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic LeukemiaBlood, 1999